Stockscreener 앱 받기
4.92
2.50%
0.12
시간 외 거래:
4.92
전일 마감가:
$4.80
열려 있는:
$4.64
하루 거래량:
178.72K
Relative Volume:
3.18
시가총액:
$186.10M
수익:
$2.76M
순이익/손실:
$-49.12M
주가수익비율:
-4.1716
EPS:
-1.1794
순현금흐름:
$-46.21M
1주 성능:
-6.46%
1개월 성능:
-6.82%
6개월 성능:
-16.47%
1년 성능:
-49.80%
1일 변동 폭
$4.49
$4.98
1주일 범위
$4.36
$5.305
52주 변동 폭
$4.22
$10.44
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
명칭
Orchestra Biomed Holdings Inc
전화
646-343-9298
주소
150 UNION SQUARE DRIVE, NEW HOPE
OBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
4.92 | 186.10M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-22 | 개시 | H.C. Wainwright | Buy |
| 2024-07-25 | 개시 | B. Riley Securities | Buy |
| 2024-01-19 | 개시 | Jefferies | Buy |
| 2023-02-24 | 개시 | Piper Sandler | Overweight |
| 2023-02-07 | 개시 | Chardan Capital Markets | Buy |
Orchestra Biomed Holdings Inc 주식(OBIO)의 최신 뉴스
Orchestra BioMed CFO Taylor Lawrence buys $4,830 in company stock - Investing.com
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Buys 5,000 Shares of Stock - MarketBeat
Orchestra Biomed CEO David Hochman buys $24,550 in stock By Investing.com - Investing.com South Africa
Orchestra Biomed CEO David Hochman buys $24,550 in stock - Investing.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stock Position Lowered by The Manufacturers Life Insurance Company - Defense World
(OBIO) Pivots Trading Plans and Risk Controls - Stock Traders Daily
OBIOOrchestra BioMed Holdings, Inc. Ordinary Shares Latest Stock News & Market Updates - StockTitan
Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting - GlobeNewswire
Orchestra BioMed to Present Breakthrough AVIM Therapy Data for Hypertension Treatment at ICI 2024 - StockTitan
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Tops Revenue Estimates - MSN
RTW Investments LP Has $42.18 Million Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - MarketBeat
Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire
Orchestra BioMed to Present at Piper Sandler Healthcare Conference | OBIO Stock News - StockTitan
Orchestra BioMed to Present at Jefferies London Healthcare Conference - MSN
HC Wainwright Has Positive Estimate for OBIO FY2024 Earnings - MarketBeat
HC Wainwright Has Optimistic Outlook of OBIO FY2024 Earnings - Defense World
Research Analysts Offer Predictions for OBIO FY2024 Earnings - Defense World
What is Chardan Capital's Forecast for OBIO FY2024 Earnings? - MarketBeat
B. Riley Lifts Earnings Estimates for Orchestra BioMed - MarketBeat
Orchestra BioMed (NASDAQ:OBIO) Earns "Buy" Rating from HC Wainwright - MarketBeat
Chardan Capital Reaffirms Buy Rating for Orchestra BioMed (NASDAQ:OBIO) - Defense World
Orchestra BioMed Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
We Think Orchestra BioMed Holdings (NASDAQ:OBIO) Needs To Drive Business Growth Carefully - Yahoo Finance
Orchestra BioMed Reports Q3 2024 Results, Advances Key Clinical Programs - MSN
Orchestra Biomed Reports Q3 2024 Financial Results - TipRanks
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update - GlobeNewswire
Orchestra BioMed Q3 Revenue Jumps 150%, Extends Cash Runway Despite Wider Losses | OBIO Stock News - StockTitan
Trading (OBIO) With Integrated Risk Controls - Stock Traders Daily
Orchestra BioMed to Participate in Jefferies London Healthcare Conference - The Manila Times
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) market cap surged US$23m last week, individual investors who have a lot riding on the company were rewarded - Simply Wall St
HC Wainwright & Co. Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Buy Recommendation - MSN
Orchestra BioMed Appoints John Mack to Board of Directors - MSN
SkyView Investment Advisors LLC Invests $163,000 in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Rhumbline Advisers Buys 17,405 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Buys 2,500 Shares of Stock - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider David P. Hochman Purchases 2,500 Shares - Defense World
Orchestra BioMed executive acquires shares worth over $47k By Investing.com - Investing.com Australia
Orchestra BioMed executive acquires shares worth over $47k - Investing.com India
Market Update: Ocular Therapeutix Inc (OCUL) Sees Negative Movement, Closing at 8.46 - The Dwinnex
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by Bank of New York Mellon Corp - Defense World
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Shares Sold by Logos Global Management LP - MarketBeat
Elevai Labs shares tumble on pricing of new stock offering - Sacramento Business Journal
Why Elevai Labs (ELAB) Stock Is Down 60% Today - Benzinga
Elevai Labs announces pricing of $8 million public offering - MSN
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - GlobeNewswire
L’Oreal partners with Evonik and Abolis to scale development of next-gen ingredients - GlobalCosmeticsNews
Video: A WONDERFUL WORLD Parades to Studio 54 - BroadwayWorld
The Cure 'Songs of a Lost World' billboard appears in NYC - Brooklyn Vegan
Exicure Shares More Than Double After Nasdaq Listing Extension - MarketWatch
Oxford Biomedica Emerges as OXB with Global Vision - TipRanks
Orchestra Biomed Holdings Inc (OBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.88%
2.65%
자본화:
|
볼륨(24시간):